Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2023

Nov 1, 2023

32106_dirs_2023-11-01_6f69750a-df3d-4f0d-979d-e1d5c8db8384.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2023-10-30

Reporting Person: Rice Michael (Former CEO and Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-10-30 Common Stock S 72603 $9.13 Disposed 347085 Direct

Footnotes

F1: The sale reported herein was made pursuant to Rule 10b5-1 (c) trading plans adopted by the reporting person effective as of 03-25-2020, 02-08-21, 02-24-2022, and 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.